Ontology highlight
ABSTRACT:
SUBMITTER: Gribben JG
PROVIDER: S-EPMC7154710 | biostudies-literature | 2020 Mar
REPOSITORIES: biostudies-literature
British journal of haematology 20191219 6
The treatment landscape in relapsed/refractory chronic lymphocytic leukaemia (CLL) has rapidly evolved over the past five years, with one such emergent treatment being the BCL2 inhibitor, venetoclax. This oral treatment has demonstrated significant clinical advantages in indicated patients, but rapid tumour debulking can lead to a treatment-related risk of the acute condition known as tumour lysis syndrome (TLS). Here, I present real patient cases to show how I have used the recommended predose ...[more]